Chicago Partners Investment Group’s CASI Pharmaceuticals CASI Stock Holding History

Chicago Partners Investment Group’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3	Closed	–	–	421
2018 Q3	$0	Hold	3	–	–	﹤0.01%	1062
2018 Q2	$0	Hold	3	–	–	﹤0.01%	956
2018 Q1	$0	Hold	3	–	–	﹤0.01%	921
2017 Q4	$0	Hold	3	–	–	﹤0.01%	885
2017 Q3	$0	Buy	+3	New	+$35	﹤0.01%	953
2017 Q2	–	Sell	-3	Closed	–	–	659
2017 Q1	$0	Hold	3	–	–	﹤0.01%	549
2016 Q4	$0	Hold	3	–	–	﹤0.01%	538
2016 Q3	$0	Hold	3	–	–	﹤0.01%	496
2016 Q2	$0	Hold	3	–	–	﹤0.01%	446
2016 Q1	$0	Hold	3	–	–	﹤0.01%	441
2015 Q4	$0	Hold	3	–	–	﹤0.01%	493
2015 Q3	$0	Hold	3	–	–	﹤0.01%	438
2015 Q2	$0	Buy	+3	New	+$45	﹤0.01%	445

Other funds holding CASI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chicago Partners Investment Group's CASI Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of CASI Pharmaceuticals (CASI) in Q4 2018, closing a stake of 3 shares.

Chicago Partners Investment Group first reported a position in CASI in Q2 2015 and held it in 13 quarters. The position peaked at $0 in Q3 2018. 54 funds tracked by Wall St. Rank hold CASI as of Q4 2018.

Chicago Partners Investment Group reported no remaining CASI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Chicago Partners Investment Group sold 3 CASI Pharmaceuticals shares in Q4 2018.
Chicago Partners Investment Group first reported a position in CASI Pharmaceuticals in Q2 2015 and held it in 13 quarters.
Chicago Partners Investment Group's CASI Pharmaceuticals position peaked at $0 in Q3 2018.
54 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.